Clinical trial
High-Dose N-Acetylcysteine in Cardiac Surgery
NCT00332631 · Austin Health, Other · Completed
Key facts
| NCT number | NCT00332631 |
|---|---|
| Title | High-Dose N-Acetylcysteine in Cardiac Surgery |
| Official title | High-Dose N-Acetylcysteine in Cardiac Surgery Patients at High-Risk of Postoperative Renal Dysfunction. |
| Lead sponsor | Austin Health, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiac Surgery and Cardiopulmonary Bypass |
| Intervention type | Drug |
| Interventions | N-acetylcysteine, Placebo |
| Enrollment | 60 |
| Start date | Aug 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Jun 1, 2006 |
| Last update posted | Jul 7, 2009 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: